X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ABBOTT INDIA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ABBOTT INDIA CADILA HEALTHCARE/
ABBOTT INDIA
 
P/E (TTM) x 23.3 35.2 66.2% View Chart
P/BV x 5.2 10.2 50.8% View Chart
Dividend Yield % 0.9 0.6 151.2%  

Financials

 CADILA HEALTHCARE   ABBOTT INDIA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-17
ABBOTT INDIA
Mar-17
CADILA HEALTHCARE/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs4605,190 8.9%   
Low Rs3054,351 7.0%   
Sales per share (Unadj.) Rs92.11,382.9 6.7%  
Earnings per share (Unadj.) Rs14.8130.2 11.4%  
Cash flow per share (Unadj.) Rs18.5137.9 13.4%  
Dividends per share (Unadj.) Rs3.2040.00 8.0%  
Dividend yield (eoy) %0.80.8 99.8%  
Book value per share (Unadj.) Rs68.0652.7 10.4%  
Shares outstanding (eoy) m1,023.7421.25 4,817.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.23.4 120.4%   
Avg P/E ratio x25.836.6 70.5%  
P/CF ratio (eoy) x20.734.6 59.8%  
Price / Book Value ratio x5.67.3 77.0%  
Dividend payout %21.630.7 70.3%   
Avg Mkt Cap Rs m391,581101,373 386.3%   
No. of employees `00016.93.1 546.7%   
Total wages/salary Rs m15,0023,453 434.5%   
Avg. sales/employee Rs Th5,594.59,531.9 58.7%   
Avg. wages/employee Rs Th890.11,119.9 79.5%   
Avg. net profit/employee Rs Th899.9897.3 100.3%   
INCOME DATA
Net Sales Rs m94,29529,387 320.9%  
Other income Rs m1,286576 223.1%   
Total revenues Rs m95,58129,963 319.0%   
Gross profit Rs m19,0363,973 479.1%  
Depreciation Rs m3,750164 2,282.4%   
Interest Rs m45020 2,205.9%   
Profit before tax Rs m16,1224,365 369.4%   
Minority Interest Rs m3380-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-30-   
Tax Rs m1,2891,598 80.6%   
Profit after tax Rs m15,1682,767 548.3%  
Gross profit margin %20.213.5 149.3%  
Effective tax rate %8.036.6 21.8%   
Net profit margin %16.19.4 170.9%  
BALANCE SHEET DATA
Current assets Rs m60,22318,906 318.5%   
Current liabilities Rs m53,0586,297 842.7%   
Net working cap to sales %7.642.9 17.7%  
Current ratio x1.13.0 37.8%  
Inventory Days Days7062 112.3%  
Debtors Days Days8822 407.4%  
Net fixed assets Rs m72,9841,159 6,298.4%   
Share capital Rs m1,024213 481.9%   
"Free" reserves Rs m68,57613,657 502.1%   
Net worth Rs m69,60013,869 501.8%   
Long term debt Rs m24,6840-   
Total assets Rs m152,20720,638 737.5%  
Interest coverage x36.8215.0 17.1%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.61.4 43.5%   
Return on assets %10.313.5 76.0%  
Return on equity %21.819.9 109.3%  
Return on capital %17.931.6 56.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m21,2800-   
Fx outflow Rs m10,8740-   
Net fx Rs m10,4060-   
CASH FLOW
From Operations Rs m13,4953,072 439.3%  
From Investments Rs m-29,103-1,554 1,872.7%  
From Financial Activity Rs m23,158-898 -2,580.0%  
Net Cashflow Rs m7,556621 1,217.7%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 8.3 7.9 105.1%  
FIIs % 5.9 0.1 5,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 17.1 64.3%  
Shareholders   44,069 18,270 241.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   NOVARTIS  JUBILANT LIFE SCIENCES  DISHMAN PHARMA  IPCA LABS  NATCO PHARMA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Extends Losses; Pharma Stocks Top Losers(Closing)

After opening the day in red share markets in India witnessed negative trading activity throughout the day, and ended well below the dotted line.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


May 21, 2018 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - DR. DATSONS LABS COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS